As clinicians, we know that lowering low-density lipoprotein cholesterol (LDL-C) with statins alone or in combination with nonstatin therapies such as a proprotein convertase subtilisin/kexin type 9 ...
An expert discusses how primary and secondary prevention differ in atherosclerotic cardiovascular disease, with secondary ...
Please provide your email address to receive an email when new articles are posted on . ApoA-I infusions may improve outcomes after acute heart attack for patients with multivessel CAD and ...
High cholesterol is a prime example of having too much of a good thing. Our bodies naturally make this substance in the liver and then transport it throughout the body for multiple functions, ...
A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough. In the Phase 3 ...
Robust efficacy data: ≥90% LDL-C reduction in non-human primates achieved within 48 hours of a single dose of EDIT-401; ≥90% LDL-C reduction in mice with high baseline LDL-C and reduced LDLR function ...
High cholesterol is a serious health issue, which increases the risk of heart disease and stroke. The most successful way to lower cholesterol levels through diet (over and above medicines), involves ...
Some of the changes that occur during the menopausal transition can affect your cholesterol levels. These include decreased estrogen, loss of muscle mass, weight gain, and insulin resistance.
New study explains why people with obesity are at a higher risk of developing cardiovascular disease
(Boston)—Obesity is a public health problem worldwide that currently affects more than 40% of adults in the U.S. Alarmingly, more than 9% of the U.S. population had severe (Class 3) obesity in 2020, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback